Sandoz, States Settle Drug Inflation Claims For $150M

Law360, New York (November 16, 2011, 6:29 PM EST) -- Sandoz Inc. on Wednesday agreed to pay $150 million to settle claims brought by a whistleblower and the states of California and Florida in multidistrict litigation accusing pharmaceutical companies of reporting inflated drug values to Medicaid programs.

The settlement resolves claims brought by California and Florida, according to a joint settlement notice and dismissal motion filed in Massachusetts federal court by Sandoz and relator Ven-A-Care of the Florida Keys Inc. The federal government also consented to the dismissal, finding its portion of the settlement to be fair, according to the notice.

Under the terms of the settlement, the U.S. will receive...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!